HC

Health Catalyst, Inc.

HCATHealthcareNASDAQ

Health Information Services · Last scanned Jul 22, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$311.1M
+1.5% YoY
Net Income
-$178.0M
-156.1% YoY
EBITDA
-$102.5M
-862.3% YoY
Free Cash Flow
$24.0M

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 15 RSI OverboughtRSI 83.5, above 70, stock may be overbought
Jul 14 RSI OverboughtRSI 84.3, above 70, stock may be overbought
About Health Catalyst, Inc.

Part of the healthcare sector, Health Catalyst, Inc. (HCAT) is listed under Health Information Services. The company carries a $155.2M market cap, placing it firmly in the micro-cap category. The company operates in two segments: Technology and Professional Services.

Where HCAT stands vs its 150-day and 200-day moving averages

As of the July 15, 2026 close, HCAT finished 27.93% above its 150-day moving average ($1.79) and 11.71% above its 200-day moving average ($2.05). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is HCAT overbought or oversold?

At the July 15, 2026 close, HCAT's RSI(14) was 83.5, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$155.2M
Fwd P/E22.75
EPS$-3.61
Beta1.57
52W Change-46.7%
ROE-103.0%
Analysis

On the balance sheet, HCAT has $108.8M in cash with $170.6M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $24.0M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -103.0% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has been uneven over recent years, ranging from $276.2M to $311.1M.

A beta of 1.57 means HCAT is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Health Catalyst, Inc.'s trajectory.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms
HCAT: Health Catalyst, Inc. Technical Analysis (200-Day MA, RSI, MACD) | Scanance